Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Connect Biopharma Holdings (CNTB) Other Working Capital Changes (2024 - 2025)

Connect Biopharma Holdings (CNTB) has disclosed Other Working Capital Changes for 2 consecutive years, with -$5.9 million as the latest value for Q4 2025.

  • Quarterly Other Working Capital Changes fell 116960.0% to -$5.9 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$518000.0 through Dec 2025, down 3600.0% year-over-year, with the annual reading at -$518000.0 for FY2025, 3600.0% down from the prior year.
  • Other Working Capital Changes hit -$5.9 million in Q4 2025 for Connect Biopharma Holdings, down from $1.8 million in the prior quarter.
  • In the past five years, Other Working Capital Changes ranged from a high of $3.5 million in Q2 2025 to a low of -$5.9 million in Q4 2025.